Stanford University, Stanford, California.
Clin Cancer Res. 2022 Oct 3;28(19):4171-4172. doi: 10.1158/1078-0432.CCR-22-1711.
Lack of prospectively planned follow-up and minimal characterization of the patient population studied complicate interpretation of circulating human papillomavirus (HPV) DNA as a prognostic biomarker for patients with HPV-associated oropharyngeal carcinoma treated with curative intent. See related article by Berger et al., p. 4292.
前瞻性随访计划的缺乏和对研究患者人群的最小特征描述,使得解读循环人乳头瘤病毒 (HPV) DNA 作为 HPV 相关口咽癌患者接受根治性治疗的预后生物标志物变得复杂。见 Berger 等人的相关文章,第 4292 页。